We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Can You Really Trust City Forecasts For HSBC Holdings plc, GlaxoSmithKline plc and Vodafone Group plc?

Can City estimates for HSBC Holdings plc (LON: HSBA), GlaxoSmithKline plc (LON: GSK) and Vodafone Group plc (LON: VOD) be trusted?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

HSBC (LSE: HSBA), GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) and Vodafone (LSE: VOD) (NASDAQ: VOD.US) all look to be to be attractively priced based on City forecasts for the next two years. The problem is, City analysts can — and do — often get these forecasts wrong, which can sometimes leave investors in a sticky position.

Indeed, over the past year alone City analysts have reduced their earnings forecast figures for HSBC, Glaxo and Vodafone by a double-digit percentage. This leaves me wondering if there could be further reductions to come. 

XXX

Revising lower

cityHSBC, Glaxo and Vodafone are three FTSE 100 behemoths. Most investors will have at least one of these stalwarts in their portfolios. As all three companies currently support a dividend yield in excess of 4.5%, compared to the FTSE 100 average of less than 3.5%, they make a dependable backbone to build a portfolio around.

Still, investors should be careful, as the City has been reducing its earnings forecasts for these companies over the past year, which has pushed valuations higher.

Vodafone has been the most affected by these ‘moving forecasts’. This time last year the City was expecting Vodafone to report earnings per share of 29p during 2014, followed by earnings of 32p per share during 2015. These forecasts included Vodafone’s share of Verizon Wireless‘s income.

Excluding the Verizon Wireless income, and the share consolidation, the City was expecting Vodafone to report earnings per share of 9p during 2014 and then 10p during 2015. However, over the past few months these estimates have fallen further and the City now expects Vodafone to report earnings of  just 6.8p per share this year and 7.2p during 2015. 

Continual adjustment

Surprisingly, over the past year, Glaxo has seen its earnings forecasts adjusted lower by a shocking 34%! The City now expects the company to report earnings of 96p per share this year — this time last year earnings of 118p per share were expected. Similarly, 2015 forecasts have fallen from 130p per share down to 101p per share. 

HSBC has also seen its earnings forecasts revised lower, although the adjustment has only been less severe. For 2014, City analysts have adjusted the bank’s earnings lower from 62p per share, down to 54p per share. Further, 2015 earnings estimates have been downgraded by 10p, from 68p per share, to 58p per share. 

What does it mean?

How does it affect investors? Well, for a start falling earnings estimates have changed company valuations. Unfortunately, this could mean that investors see valuations change for the worse as analysts revise forecasts down further. 

However, dividend investors do not need to worry. In most cases City dividend forecasts are correct, as they are based on figures supplied by company management teams.

Rupert Hargreaves owns shares of GlaxoSmithKline. The Motley Fool recommends GlaxoSmithKline.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »